Hanazono Y - Search Results

1

In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model.

Hanazono Y, Nagashima T, Takatoku M, Shibata H, Ageyama N, Asano T, Ueda Y, Dunbar CE, Kume A, Terao K, Hasegawa M, Ozawa K. Hanazono Y, et al. Gene Ther. 2002 Aug;9(16):1055-64. doi: 10.1038/sj.gt.3301781. Gene Ther. 2002. PMID: 12140733

2

Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage.

Hanazono Y, Yu JM, Dunbar CE, Emmons RV. Hanazono Y, et al. Hum Gene Ther. 1997 Jul 20;8(11):1313-9. doi: 10.1089/hum.1997.8.11-1313. Hum Gene Ther. 1997. PMID: 9295126

3

Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability.

Tisdale JF, Hanazono Y, Sellers SE, Agricola BA, Metzger ME, Donahue RE, Dunbar CE. Tisdale JF, et al. Among authors: hanazono y. Blood. 1998 Aug 15;92(4):1131-41. Blood. 1998. PMID: 9694700 Free article.

4

Abrogation of TGF-beta activity during retroviral transduction improves murine hematopoietic progenitor and repopulating cell gene transfer efficiency.

Yu J, Soma T, Hanazono Y, Dunbar CE. Yu J, et al. Among authors: hanazono y. Gene Ther. 1998 Sep;5(9):1265-71. doi: 10.1038/sj.gt.3300732. Gene Ther. 1998. PMID: 9930329

5

Expression of interferon-gamma by stromal cells inhibits murine long-term repopulating hematopoietic stem cell activity.

Yu JM, Emmons RV, Hanazono Y, Sellers S, Young NS, Dunbar CE. Yu JM, et al. Among authors: hanazono y. Exp Hematol. 1999 May;27(5):895-903. doi: 10.1016/s0301-472x(99)00009-0. Exp Hematol. 1999. PMID: 10340406 Free article.

6

Hematopoietic stem cell gene therapy: a current overview.

Kume A, Hanazono Y, Mizukami H, Urabe M, Ozawa K. Kume A, et al. Among authors: hanazono y. Int J Hematol. 1999 Jun;69(4):227-33. Int J Hematol. 1999. PMID: 10407578 Review.

7

In vivo marking of rhesus monkey lymphocytes by adeno-associated viral vectors: direct comparison with retroviral vectors.

Hanazono Y, Brown KE, Handa A, Metzger ME, Heim D, Kurtzman GJ, Donahue RE, Dunbar CE. Hanazono Y, et al. Blood. 1999 Oct 1;94(7):2263-70. Blood. 1999. PMID: 10498598 Free article.

8

Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model.

Heim DA, Hanazono Y, Giri N, Wu T, Childs R, Sellers SE, Muul L, Agricola BA, Metzger ME, Donahue RE, Tisdale JF, Dunbar CE. Heim DA, et al. Among authors: hanazono y. Mol Ther. 2000 Jun;1(6):533-44. doi: 10.1006/mthe.2000.0072. Mol Ther. 2000. PMID: 10933978 Free article.

9

Primary T lymphocytes as targets for gene therapy.

Hanazono Y, Brown KE, Dunbar CE. Hanazono Y, et al. J Hematother Stem Cell Res. 2000 Oct;9(5):611-20. doi: 10.1089/15258160050196641. J Hematother Stem Cell Res. 2000. PMID: 11091484 Review.

10

Gene transfer into nonhuman primate hematopoietic stem cells: implications for gene therapy.

Hanazono Y, Terao K, Ozawa K. Hanazono Y, et al. Stem Cells. 2001;19(1):12-23. doi: 10.1634/stemcells.19-1-12. Stem Cells. 2001. PMID: 11209087 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters